FDC LTD
GenericsFDC LTD is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Dermatology.
FDC LTD's Key Drugs
FDC LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
FDC LTD's Recent FDA Approvals
New NDA/BLA approvals for FDC LTD over the last two years — novel drugs only, excluding generics and label supplements.
FDC LTD's Therapeutic Areas
FDC LTD's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Infectious Disease. Weighted by commercial stage — approved drugs count most, then late-stage trials.
FDC LTD's Top Competitors
FDC LTD's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and GE HEALTHCARE. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
FDC LTD Pipeline Snapshot
Active clinical trials for FDC LTD across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2008-04-30
- Latest
- 2026-06-10
- Applications
- 14